Lv1
20 积分 2023-03-24 加入
Generation and Characterization of Mirikizumab, a Humanized Monoclonal Antibody Targeting the p19 Subunit of IL-23
1个月前
已完结
Targeting the Interleukin 23 Pathway in Inflammatory Bowel Disease
1个月前
已完结
IL‐4 and IL‐13 are not involved in IL‐31‐induced itch‐associated scratching behaviour in mice
2个月前
已完结
Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis
2个月前
已完结
Long-Term Effectiveness and Reasons for Discontinuation of Dupilumab in Patients With Atopic Dermatitis
2个月前
已完结
IL-31–generating network in atopic dermatitis comprising macrophages, basophils, thymic stromal lymphopoietin, and periostin
2个月前
已完结
Coupling antigens from multiple subtypes of influenza can broaden antibody and T cell responses
2个月前
已完结
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials
2个月前
已完结
DOP031 Anti-IL-7 receptor plus anti-IL12/23 combination induces complete histological normalization in chronic colitis
2个月前
已完结
A tissue-specific endothelial cell molecule involved in lymphocyte homing
3个月前
已完结
皖公网安备34019202002308
